Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Stock indices are calculated by dedicated index providers using specified methodologies and governance processes. This article explains who does the work and why it matters.
16,076 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Nvidia’s upcoming earnings have many traders eyeing the odds. Prediction markets are whispering a high probability of...
A vivid look at the origins of Amazon’s empire and the investors who struck it rich long ago. Learn the core moves th...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Canaccord Genuity lowers AeroVironment's target to $330 but preserves a Buy rating, underscoring long-term optimism a...
As AI, cloud, and cybersecurity accelerate, five hyper-growth tech stocks 2026 could power a bold investment portfoli...
Palantir stock slides further from its 52-week high even after a standout Q4, as investors weigh a rich valuation aga...
Tokenized stocks are moving from concept to reality as major exchanges edge toward on-chain equity trading. This repo...
Macy’s stock surged after the retailer posted a third straight quarter of rising comparable sales, surpassing expecta...
Retirement success isn’t about chasing one hot stock. It’s about a well-balanced mix of growth, income, and safety. L...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...
IonQ is set to release Q1 2026 results after the bell, with investors weighing growth across five acquisitions, a Sky...